discussed by Thomsen et al. 3 These discrepancies are possibly due to the multifactorial nature of fertilization or the sperm selection process and need to be addressed in larger, controlled multi-center studies.
The impact of obesity on male reproductive health remains a contested topic as evidence is inconclusive and inconsistent. 1,2 Even more debatable is the effect of male obesity in assisted reproduction. In the manuscript, "the impact of male overweight on semen quality and outcome of assisted reproduction" published in Asian Journal of Andrology, Thomsen et al. 3 investigated the effect of male obesity on fertilization outcomes in intrauterine insemination, in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) programs further contributes to the increasing body of evidence in this field.
Thomsen et al. 3 showed no significant impact of male obesity (body mass index (BMI) >30) on various semen parameters, IVF rates, number of good quality embryos and implantation or pregnancy outcomes in a set of 74 males, when compared to 268 overweight (BMI = 25-29.9) and 259 normal weight (BMI = 20-24.9) patients attending assisted reproductive technology (ART) programs. It is well-established that male obesity negatively affects the endocrine system resulting in hypogonadism and increased estrogen. 4 In many cases, various metabolic changes directly or indirectly negatively influence male reproduction pathways, including hyperinsulinemia, hyperleptinemia, oxidative stress and low-grade systemic inflammation (Leisegang et al. unpublished). These changes and their potential impact on spermatogenesis and sperm function may provide some insight into inconsistent results published regarding obesity and male fertility and stimulate investigation of metabolic parameters that may better predict pregnancy outcomes than BMI alone. In the discussion, the authors reported that the lack of altered semen parameters is not affected by an altered endocrine profile. However, there is no evidence of follicle-stimulating hormone or testosterone concentrations in males reported in this paper. Therefore, it is difficult to assume that these patients had significant differences in the endocrine profile.
Yet, such investigations are important as the impact of paternal obesity on reproductive outcomes is under-investigated when compared to female obesity, particularly in ART. With high financial and emotional investment in the ART process by couples, it is important to identify factors that may decrease successful pregnancy and live birth rates in order to adequately advise patients. Based on these results, and supported by the literature, male weight should not be considered as a potential confounder in the outcome of ART. Nevertheless, there is evidence that male obesity negatively influences IVF outcomes as 
